Background-Serosorting is increasingly assessed in studies of MSM. Most research studies have measured serosorting by combining reported unprotected anal intercourse (UAI) and the occurrence of participant and partner same HIV status (seroconcordance). The CDC definition of serosorting also incorporates intent to be in such a partnership, although few studies incorporate both intent and behavior into their measures.
Introduction
Among 49,273 HIV diagnoses in the United States in 2011, 62% are estimated to have occurred due to sexual transmission among men who have sex with men (MSM). 1 Some MSM engage in seroadaptive strategies such as serosorting, which CDC defines as "choosing a sexual partner known to be of the same HIV serostatus, often to engage in unprotected sex, in order to reduce the risk of acquiring or transmitting HIV." 2 Inherent in the construct of CDC's definition is that the choice of a same status (seroconcordant) partner is made "in order to reduce the risk" -i.e., that serosorting is not defined just by having a partner of the same serostatus, but that serosorting requires that the reason for this was the intention to reduce risk of HIV transmission.
Serosorting is a complex behavior occurring across time and multiple partnerships, making it difficult to operationalize a definition. A literature review of 51 studies identified two main definitions being used in studies of serosorting: a 'behavioral-based' definition that considers serosorting solely based on sexual behaviors (i.e. having a seroconcordant UAI partner), and an 'identity-based' definition that involves an explicit statement of intent to serosort. 3 Both behavioral-and identity-based definitions may be problematic. Behavioral definitions [4] [5] [6] [7] [8] [9] [10] [11] are limited to the extent that the proportion of behavior classified as serosorting is unintentional, due to chance. This may be particularly true for HIV negative (HIV−) MSM. A majority of their partnerships would be expected to be seroconcordant negative based solely on chance, because 81% of MSM are estimated to be HIV−. 12 Alternately, intent-focused definitions 7, [13] [14] [15] [16] [17] are limited due to imperfect matches between intention and behavior. Studies of serosorting have not sought to explore the relative benefits and differences of these two types of measures, which are usually not implemented simultaneously. Therefore, it is unclear which of the two methods, or a combination thereof, should be used in future studies.
In San Francisco, an innovative approach used a baseline 'identity-based' intention statement, and assessed a 'behavior-based' definition at 12-month follow. 16, 18 For HIV− men who stated intention to only have seroconcordant partners (pure serosorting) at baseline, 38% had enacted that behavior at a 12-month follow-up, compared to 15% of HIV − men who had not stated such intention. The authors of this pioneering study note that the results may not generalize to other settings beyond San Francisco, and that for the case of condom serosorting, only 3% of HIV− men behaviorally enacted their stated intent. Moreover, even for pure serosorting, a majority of HIV− men did not behaviorally enact their stated intent.
Whether serosorting is to be encouraged, discouraged or ignored involves determination of whether it is an effective HIV prevention strategy. The literature on this question is mixed, with one study that assessed HIV incidence indicating serosorting is protective against HIV transmission, 19 while two other studies that assessed HIV positive cases among men previously undiagnosed with HIV found that serosorting had limited or no protective value. 6, 20 All of these studies used behavioral definitions of serosorting, and generalization of their estimates is limited by misclassification bias, to the extent that some men may not be intentionally serosorting. Moreover, understanding serosorting intention levels would provide information on the degree to which serosorting is a preconceived strategy that merits attention in the design of HIV prevention programs.
The present investigation seeks to fill several key gaps currently absent from the literature by using a national, internet-based sample to explore measurement of seroconcordance both with and without a statement of intention. Specifically, to our knowledge, no prior study has provided data of national scope regarding (1) the prevalence of intentional serosorting among seroconcordant partnerships, and its distribution among all sexual partnerships, (2) socio-demographic correlates of both seroconcordance and intentional serosorting and (3) the association between seroconcordance, intentional seroconcordance and UAI. We hypothesized that men who described their seroconcordance as intentional would be more likely to practice UAI, therefore supporting the CDC definition of serosorting as a behavior that should be primarily considered as an intentional phenomenon.
Methods

Study design
Data were analyzed from the baseline assessment of a prospective study of home HIV testing among MSM. 21, 22 Internet-using MSM with a reported US residence were recruited by banner advertising, from August-December 2010. Respondents eligible to participate in the study were men ≥18 years old that reported sex with ≥1 male partner in the prior 12 months. Zip code data were available from a subset of participants in the present study who were also enrolled in a follow-up study (n=930). This group reported residence in the Northeast (15%), the Midwest (19%), the South (41%), the West (26%) and Puerto Rico (1%). The study was approved by Emory University's Institutional Review Board (Protocol IRB00031326).
Measures
For this analysis, we used data from measures of demographics, participant sexual experiences, and behaviors with recent sexual partners. Measures of participant demographics and aggregate sexual behaviors were based on the instrument used in the first MSM cycle of the CDC's National HIV Behavioral Surveillance System (NHBS). 23 Participant sexual experiences were assessed based on a 6-month recall period to minimize recall bias due to the detailed nature of the items. For up to five recent sex partners, participants completed a partner module that collected partner demographic and sexual risk behavior information. The partner module was developed based on questions in the NHBS, and adapted based on findings from focus groups and a Facebook.com pilot with over 1,000 participants.
Each sexual partnership's (hereafter termed 'partnership') questions assessed sexual repertoire, relationship type, where the respondent met the partner, partner's HIV status, and participant's intent to be in a seroconcordant relationship. Sexual repertoire was assessed with, "Have you had anal sex with (partner name) in the past six months?" and "Have you had unprotected anal sex with (partner name) in the last six months?" A single variable was created based on answers to these questions, with categories of ever UAI and all other sex. Relationship type was categorized into one-time casual, repeated casual or main based on two items: "Did you have sex with (partner name) once, or more than once during the last 6 months?" and "Is (partner name) someone you feel committed to above all others (someone you might call your boyfriend or significant other, life partner or husband)?" Meeting venue was measured with, "Where did you first meet (partner name)?" This variable was categorized into online, through friends/work/school and other. Partner's HIV status before first sex was determined with, "Did you and (partner's name) share your HIV statuses before having sex?" and "What was (partner's name) status?" Partnerships were classified as seroconcordant if the participant and partner's HIV statuses were the same. To assess intent to serosort, the participant rated on a five-point Likert scale, "How important was the knowledge that (partner's name) was (partner's HIV status) in deciding to first have sex with (partner)." Likert scale points were: "Not important at all", "Slightly important", "Moderately important", "Very important", and "Extremely important." We considered seroconcordance to be intentional when "Very important" or "Extremely important" options were selected.
Analysis
Respondent demographic data were analyzed at the individual level; data related to respondents' sexual partners were analyzed at the partner level. All analyses were stratified by reported participant HIV status. Participants with unknown HIV status (22%: 774 out of the total sample of 3519) were excluded from analyses involving serosorting, because awareness of one's own HIV status is requisite for the act of serosorting.
In Figure 1 , we used unadjusted percents and counts to explore the distribution of intentional seroconcordance in our sample, stratified by participant HIV status, partner seroconcordance, and UAI practice. Table 1 describes differences in the distributions of participant demographic characteristics (age, income, education, sexual orientation and race/ ethnicity) by participants' HIV status (HIV+, HIV− or unknown), using Pearson's 2 values. Table 2 describes differences in distributions of partner characteristics (partner type, sex type, and meeting locale) by participants' HIV status, using odds ratios (OR). In Table 3 , we used OR to assess associations between demographic and partnership characteristics and (1) partnership seroconcordance and (2) partnership intentional seroconcordance. All OR were generated from generalized estimating equation (GEE) regressions with an exchangeable correlation matrix and logit link function. GEE regressions were used to account for repeated observations of participants within the partnership data.
In Table 4 , we conducted a series of multivariable logistic regressions with UAI as the dependent variable and either seroconcordance or intentional seroconcordance as the independent variable, with all models based on the GEE parameters mentioned above. The purpose of developing these models was to understand the direction and magnitude of association between serosorting intention and UAI. To achieve less biased estimates, we controlled for a set of participant demographic variables and partnership variables shown to be significant predictors of UAI in prior research, which may also be associated with the two seroconcordance outcomes. 14, [24] [25] [26] [27] [28] Sensitivity analyses assessed whether changes in how we dichotomized serosorting intent impacted the direction or significance of study findings regarding its relation to UAI. All analyses were conducted in STATA 11.2. 29
Results
Overall, 6,104 men began the online survey, and 4,138 began the section regarding sex partners, a response rate of 68%. Of this group, 3,519/4138 (85%) had sex with a man in the previous six months. Table 1 shows demographic features of the 3,519 respondents who had sex with men in the last six months, by reported HIV status. At the individual level, MSM unaware of their status (HIVu) were younger, poorer and less educated than HIV− and HIV+ MSM. HIVu men were less likely than HIV− and HIV+ men to identify as homosexual (70, 81 and 90% respectively; p<0.001). Racial composition among the groups was similar, with the exception of non-Hispanic blacks being over-represented in the HIV+ group (p<0.001).
From 3,519 respondents who reported sex with a man in the previous six months, we collected participant HIV status and partnership type data on 8,558 partnerships in the prior six months (i.e., each man reported, on average, data on 2-3 sexual partners). Table 2 shows characteristics of these partnerships by participant's HIV status. Nearly half were UAI partners, and less than one-quarter were classified as main partners. Approximately half of partners were met online. A higher proportion of HIV+ men reported UAI than HIV− and HIVu men (56%, 43% and 44%, respectively; p<0.001). Also, a lower proportion of HIV+ men reported main partnerships than HIV− and HIVu men (17%, 24% and 23%, respectively; p<0.001). A higher proportion of HIV+ men's partners were met online than among HIV− and HIVu men (59%, 52% and 48%, respectively; p<0.05). Nearly half of all partnerships involved an unknown serostatus (HIVu) respondent or partner: 20% of partnerships involved HIVu respondents and any partners (R:HIVu, P:any) and 28% involved known status participants and HIVu partners (R:HIV−, P:HIVu or R:HIV +, P:HIVu). For all partnerships with an HIVu member, seroconcordance or serodiscordance could not have been established at the time of the partnership, and therefore serosorting was not possible. The reason for unknown HIV status differed for HIVu respondents and HIVu partners. Most HIVu respondents (90%) reported never having received an HIV test, but nearly all respondents with HIVu partners reported never discussing their partner's serostatus (98%), an issue further explored in a separate analysis. 30 Levels of UAI were high across all subgroups in the analysis: the lowest level was over onethird (37%) for R:HIV−, P:HIVu partnerships, and the highest level was over three-quarters (80%) for R:HIV+, P:HIV+ partnerships. For all other partnership groupings, the range of UAI levels was remarkably narrow (43-50%) given that this figure includes diverse partnerships such as R:HIV−, P:HIV+; R:HIV−, P:HIV−; and R:HIV+, P:HIVu partnerships.
Among HIV− respondent partnerships, known serodiscordance (R:HIV−, P:HIV+) was rare (2%). This level is less than would be expected by chance, given that 10% of the overall sample was HIV+. Although HIV− respondents reported fewer than expected serodiscordant partnerships based on random mixing alone, one-third (34%) of their partnerships involved HIVu partners.
Among HIV+ respondent partnerships, fewer were known serodiscordant (R:HIV+, P:HIV −) (29%) than would be expected based on the prevalence of HIV− men (69%) in our sample. Similarly, more HIV+ respondent partnerships were serconcordant (30%) than would be expected based on random partnering based on the 10% HIV prevalence in our sample. Table 3 shows proportions of partnerships which were seroconcordant, and proportions of these seroconcordant partnerships classified as intentionally seroconcordant. Overall, the proportion of seroconcordant partnerships was 64% for HIV− respondents and 30% for HIV + respondents; within seroconcordant partnerships, intention to choose a seroconcordant partner was 80% for HIV− respondents and 48% for HIV+ respondents. The intersection of seroconcordance and stated intention shows that 51% of HIV− partnerships and 15% of HIV + partnerships were intentionally seroconcordant.
Demographic and behavioral factors associated with being in a seroconcordant partnership were largely similar for HIV− and HIV+ respondents, except for age. HIV+ respondents aged ≥ 40 years were significantly more likely to be in seroconcordant partnerships than their age 18-24 counterparts (odds ratio (OR) 3.3; 95% confidence interval (CI): 1.5, 7.0), but age had no significant association with seroconcordance for HIV− partnerships (OR 1.0; CI: 0.8, 1.2). Relative to white respondent partnerships, point estimates indicated decreases in odds of seroconcordance for HIV− black (OR 0.72; CI: 0.58, 0.89) and HIV+ black (OR 0.72; CI: 0.44, 1.2) respondent partnerships. One-time casual partners were less likely to be seroconcordant than main partners for HIV− (OR 0.43; CI: 0.38, 0.49) and HIV+ (OR 0.67; CI: 0.46, 0.98) respondents. Online partnerships were more likely than offline partnerships to be seroconcordant for HIV− (OR 2.1; CI: 1.8, 2.4) and HIV+ (OR 1.7; CI: 1.2, 2.5) respondents.
Among HIV− seroconcordant partnerships, intention to be in such a partnership was associated with being ≥ 40 years of age (OR 0.56; CI: 0.42, 0.74) and bisexuality (OR 1.7; CI: 1.2, 2.4). Among HIV+ seroconcordant partnerships, intention was associated with participant's black race (OR 2.5; CI: 1.1, 5.8), Hispanic ethnicity (OR 9.6; CI: 2.0, 47) and meeting a partner online (OR 1.9; CI: 1.2, 2.9). Thus, seroconcordance and intentional seroconcordance shared few demographic associations.
Models of associations between UAI and the independent variable, any seroconcordance or intended seroconcordance, were stratified by participant serostatus (Table 4 ). For HIV− men, a small but significant association was found between seroconcordance and UAI (OR 1.2; CI: 1.0, 1.3; p = 0.03). However, UAI was not associated with intended seroconcordance (OR 1.1; CI: 0.99, 1.3). For HIV+ men, seroconcordance was strongly associated with UAI (OR 3.2; CI: 2.2, 4.6), and intended seroconcordance was similarly associated (OR 1.9; CI: 1.3, 2.9). Across all four models, main partnership was strongly associated with UAI. For HIV− men, the association (OR 5.8; CI: 5.0, 6.8) was substantially stronger than the association between seroconcordance and UAI described above. Indicating a potential dose-response relationship, casual repeated partnerships, compared to one-time partnerships, were also associated with UAI across the models. The only other significant control variable across models of UAI was ethnicity, with "other" ethnicity members less likely to report UAI than White, non-Hispanics. Sensitivity analyses indicated that using different cut-points on the Likert scale to dichotomize the serosorting intention variable did not alter the direction or significance of study findings regarding serosorting and its relation to UAI.
Discussion
We found high levels of stated intention to be in a seroconcordant relationship among HIV− seroconcordant partnerships (80%), and moderate levels (48%) among HIV+ seroconcordant partnerships. For HIV− men, nearly two-thirds of all their partnerships were seroconcordant, and most of that seroconcordance was intended. High rates of stated intention indicate that seroconcordance was not solely due to social or sexual network structures, but instead may be the product of a deliberate harm-reduction strategy. Supporting this hypothesis was the rarity of known serodiscordant relationships (2%) among HIV− respondents relative to HIV prevalence in our sample of 10%. Some HIV− men might avoid the cognitive dissonance of known serodiscordant partnerships, instead taking on undefined risk by not ascertaining their partner's serostatus (34% of HIV− men's partnerships were with partners of unknown serostatus).
About one-third of HIV+ men's partnerships were seroconcordant, with just under half of these reported as intentionally concordant. Seroconcordant HIV+ partnerships made up a higher proportion of HIV+ men's partnerships than would be expected by chance, but the absolute level was low (30%). Like the present study, other research has found seroconcordance among both HIV− and HIV+ men to occur at higher than expected levels. 16 Associations between UAI and different measures of serosorting did not support our hypothesis that men who described their seroconcordance as intentional would be more likely to practice UAI. Our findings regarding the limitations of seroconcordance intent in predicting UAI behavior, however, echo a meta-analysis that concluded that across multiple domains, health behavior intentions accounted for only 22% of the variance in health behaviors. 31 Measurement of the 'intent to serosort' construct has been fraught with difficulties relating to time order, improperly aggregated behavior, and the degree to which pre-imposed strategies are formulated and subsequently influence sexual decisions (in addition to other, more common behavioral measurement limitations such as recall bias). Our measures attempted to mitigate problems relating to time order by assessing participant's knowledge of partner's HIV status prior to first sex. Further, our measures sought to mitigate the need for participants to aggregate behavioral strategy across different partnerships, because in actuality men may use different strategies in different situations. Yet our measures were limited to the extent that participants either 1) did not approach sexual partnerships with a conscious, pre-formulated HIV prevention plan or 2) did not consistently implement within partnerships such HIV prevention plans. A separate study found that over half of HIV− MSM practicing UAI outside of their main partnership reported that they had no specific HIV risk reduction strategy; 32 this may indicate that, for a substantial proportion of individuals, conscious and pre-formulated plans may not accurately describe their HIV−risk reduction behaviors.
Several possible scenarios could explain why measurement of intention did not lead to stronger associations with UAI. First, although seroconcordance was associated with UAI, intention might have no impact on this relationship. If this were the case, using a stated intention measure would effectively reduce sensitivity of the "any seroconcordance" measure and would misclassify respondents. Another possibility is that our measure of intent is not adequate to detect a true relationship between seroconcordance intentionality and UAI. The most probable scenario is that some combination of the above factors influenced our findings regarding intent and UAI. Also, it is possible that, despite our large number of respondents and partnerships, we did not have sufficient power to detect differences between the magnitude of the associations between UAI and the two definitions of seroconcordance. Despite uncertainty regarding intent, this study yields clear implications for future research. The CDC's definition of serosorting requiring intent may reduce sensitivity unnecessarily. Upcoming studies should always include a behavioral measure of serosorting, based on seroconcordance and UAI, and not rely solely on identity measures of intentional serosorting.
Regardless of intentionality, seroconcordance was strongly associated with UAI for HIV+ men and weakly associated with UAI for HIV− men, findings very similar to those from other studies of serosorting. 10, 33 Except the small (2%) set of HIV+ seroconcordant partnerships, there was remarkably little variation in levels of UAI across all other partnerships grouped by seroconcordance in the study: 37%-50%. This translated to very different partnership types having similar levels of UAI. This could be seen as indicating continued and high overall UAI, but also could be interpreted as a lack of substantial increase in UAI among HIV− men in seroconcordant relationships (45%) relative to HIV− men in sero-unknown (37%) or serodiscordant (48%) relationships. This finding, combined with failure of intention to improve the association between seroconcordance and UAI, calls into question the plausibility of incorporating serosorting behaviors among HIV− men into HIV prevention interventions.
Out of all factors in our models of UAI, main partnership had the strongest correlation, indicating the importance of relationship commitment as a factor in sexual practices. Data from the NHBS and other surveys of MSM also show main partnership to be highly associated with UAI, a contributor to the estimate that a substantial proportion of incident HIV transmissions occur within main partnerships. 24, 25 The implication of small effects of seroconcordance and large effects of main partnership on UAI among HIV− men indicates prevention programs are likely to benefit from increased focus on factors that develop during relationships, such as trust and commitment.
Our study had a number of important limitations. Our respondents comprised a sample of Internet-using men who opted into a banner-ad based survey, making our findings subject to selection bias. Study findings therefore are not representative of all US MSM, or all internetusing MSM. The cross-sectional nature of our data also limited our assessments of relationships to associations. Because we asked participants to report retrospectively on their intent, data are subject to recall bias; it is not clear what impact such bias might have on our results. The median interval from relationship initiation to interview was less than six months, however, which somewhat mitigates this concern. Additionally, we relied on selfreported data for all measures, which could result in social desirability bias. We excluded HIVu participants only from analyses directly related to serosorting, because serosorting is not a meaningful strategy without knowledge of one's own serostatus. Exclusion of this group is non-trivial, because HIVu respondents were younger, lower-income, less educated and less likely to identify as homosexual than their known serostatus peers. A similar limitation is that all partnerships men avoided, such as an HIV− man avoiding an HIV+ partner, were by definition not captured in our measures of sexual behavior. Despite these limitations, the present study's methodology also has some advantages. First, by conducting an online survey, we were able to collect data from across the United States. Second, our measurement of intent and seroconcordance sought to resolve a long-standing question regarding the definition of serosorting, and the HIV prevention significance of intentional versus unintentional seroconcordance.
According to our findings, understanding whether seroconcordance is intentional is not necessary to understand the relationship between seroconcordance and UAI. We found a small, but significant, association between HIV− partnership seroconcordance and higher levels of UAI. For men living with HIV infection, having an HIV+ partner was strongly associated with UAI, despite the reality that these men less often expressed that their serosorting was intentional than did their HIV− counterparts. These results indicate that intention to be in a seroconcordant partnership may be less determinant of UAI than seroconcordance itself. HIV status, seroconcordance, sexual behavior, and serosorting intentionality reported by MSM in an online HIV prevention study, United States, 2010. UAI: unprotected anal intercourse; other sex: oral sex or condom protected anal sex. 
